Actively Recruiting
Standardized Implementation and Quality Assessment System for Confocal Enteroscopy
Led by Shanghai Jiao Tong University School of Medicine · Updated on 2026-01-23
600
Participants Needed
8
Research Sites
156 weeks
Total Duration
On this page
Sponsors
S
Shanghai Jiao Tong University School of Medicine
Lead Sponsor
S
Shanghai Zhongshan Hospital
Collaborating Sponsor
AI-Summary
What this Trial Is About
Confocal technology, hailed as "optical biopsy," enables real-time cellular-level histological examination of mucosal surfaces. Its integration with double-balloon enteroscopy significantly enhances the clinical feasibility of targeted biopsy, early diagnosis, and endoscopic staging for small bowel diseases such as inflammatory bowel disease. Currently, confocal endoscopy is primarily applied to upper and lower gastrointestinal tract diseases, leaving small bowel pathologies largely unexplored. Consequently, establishing a diagnostic framework for small bowel tumors and non-neoplastic lesions using confocal enteroscopy, alongside developing quality assessment standards for its operational procedures, is of paramount importance.
CONDITIONS
Official Title
Standardized Implementation and Quality Assessment System for Confocal Enteroscopy
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Aged 18-70 years and scheduled to undergo small-bowel endoscopy.
- Able to provide written informed consent and willing to participate in the study.
- Certified gastroenterologists with an intermediate (or higher) professional title.
- Have completed formal training and passed competency assessments in gastroscopy, colonoscopy, and small-bowel endoscopy.
- Willing to participate and able to provide written informed consent.
You will not qualify if you...
- Poor general condition, severe hepatic or renal insufficiency, or inability to tolerate complete endoscopic examination.
- Known hypersensitivity to any study-related agents (fluorescein sodium, polyethylene glycol, lidocaine mucilage).
- Currently enrolled in another clinical trial.
- Never performed endoscopic procedures.
- Endoscopic procedure or image-reading volume less than 100 cases in the past 2 years.
- Medical license revoked or currently suspended for any reason.
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 8 locations
1
Renji Hospital Anhui Hospital
Hefei, Anhui, China
Actively Recruiting
2
Ningbo Hangzhou Bay Hospital
Ningbo, Zhejiang, China
Actively Recruiting
3
Kashgar Second People's Hospital
Kashgar, China
Actively Recruiting
4
Huashan Hospital, Fudan University
Shanghai, China
Actively Recruiting
5
Renji Hospital
Shanghai, China
Actively Recruiting
6
Ruijin Hospital, Shanghai Jiao Tong University School of Medicine
Shanghai, China
Actively Recruiting
7
Shanghai Sixth People's Hospital
Shanghai, China
Actively Recruiting
8
Zhongshan Hospital, Fudan University
Shanghai, China
Actively Recruiting
Research Team
X
Xiaobo Li, MD. PhD
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here